Pharma company ACDIMA is shopping for a new acquisition target, CEO Olfat Ghorab tells Al Borsa. The company’s board of directors has also signed off on new planned investments that will see ACDIMA either add new production lines to its existing capacity or invest in a promising pharma manufacturer, she adds. The state-owned ACDIMA had reportedly acquired United Pharma IV last August in a transaction valued at over EGP 320 mn.